General MedicationsIMPLANTATIONStandard
NEXPLANON
ETONOGESTREL
Standard Dose
68MG/IMPLANT
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NEXPLANON is listed in Drugs@FDA under application 021529 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ETONOGESTREL Form and strength IMPLANT;IMPLANTATION - 68MG/IMPLANT Sponsor ORGANON Submission history Latest submission status date: 2026-01-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEXPLANON is listed in Drugs@FDA under application 021529 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETONOGESTREL Form and strength IMPLANT;IMPLANTATION - 68MG/IMPLANT Sponsor ORGANON Submission history Latest submission status date: 2026-01-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.